The invention relates to a composition for treating degenerative joint diseases having improved effectivity, wherein the composition comprises collagen hydrolysate and rosehip powder and/or extract, wherein the weight ratio of collagen hydrolysate to rosehip powder and/or extract, based on dry weight, is in the range from approximately 2:1 to approximately 100:1.